These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Economic burden prior to COPD diagnosis: a matched case-control study in the United States. Akazawa M, Halpern R, Riedel AA, Stanford RH, Dalal A, Blanchette CM. Respir Med; 2008 Dec; 102(12):1744-52. PubMed ID: 18760581 [Abstract] [Full Text] [Related]
5. Risk of hospitalizations/emergency department visits and treatment costs associated with initial maintenance therapy using fluticasone propionate 500 microg/salmeterol 50 microg compared with ipratropium for chronic obstructive pulmonary disease in older adults. Blanchette CM, Akazawa M, Dalal A, Simoni-Wastila L. Am J Geriatr Pharmacother; 2008 Aug; 6(3):138-46. PubMed ID: 18775388 [Abstract] [Full Text] [Related]
7. Cost and utilization of COPD and asthma among insured adults in the US. Blanchette CM, Broder M, Ory C, Chang E, Akazawa M, Dalal AA. Curr Med Res Opin; 2009 Jun; 25(6):1385-92. PubMed ID: 19419342 [Abstract] [Full Text] [Related]
13. Healthcare utilization and costs of patients with rosacea in an insured population. Romanowicz M, Stephenson JJ, Del Rosso JQ, Lenhart G. J Drugs Dermatol; 2008 Jan; 7(1):41-9. PubMed ID: 18246697 [Abstract] [Full Text] [Related]